MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
2170.86%
Quick Ratio
2170.86%
Cash Ratio
1129.82%
Debt to Asset Ratio
4.97%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Marketable securities - noncurre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other payab...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
420,078
193,712
128,390
113,713
Marketable securities
362,498
354,074
438,974
462,404
Receivable from collaboration partner
13,416
53,663
121
583
Contract asset
3,366
-
-
-
Prepaid expenses and other current assets
7,790
12,006
10,089
9,724
Total current assets
807,148
613,455
577,574
586,424
Marketable securities - noncurrent
66,875
72,548
78,638
102,703
Property and equipment, net
3,456
3,778
3,860
4,100
Restricted cash - noncurrent
287
288
287
287
Operating lease right-of-use asset
6,946
7,390
7,829
8,174
Other non-current assets
832
-
-
-
Total assets
885,544
697,459
668,188
701,688
Accounts payable
3,459
8,437
5,339
5,646
Accrued expenses and other payables
21,667
17,491
28,269
22,868
Deferred revenue
9,659
6,282
9,550
14,200
Operating lease liability
2,396
2,339
2,283
2,228
Total current liabilities
37,181
34,549
45,441
44,942
Deferred revenue - noncurrent
-
-
-
2,788
Operating lease liability - noncurrent
6,820
7,437
8,040
8,521
Total liabilities
44,001
41,986
53,481
56,251
Common stock, 0.00001 par value, 180,000,000 shares authorized 64,672,032 and 62,577,897 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
1
1
1
1
Additional paid-in capital
1,146,409
1,122,629
1,084,736
1,071,198
Accumulated other comprehensive (loss) income
-828
-269
641
525
Accumulated deficit
-304,039
-466,888
-470,671
-426,287
Total stockholders' equity
841,543
655,473
614,707
645,437
Total liabilities and stockholders' equity
885,544
697,459
668,188
701,688
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$420,078K (149.24%↑ Y/Y)Marketable securities$362,498K (-9.81%↓ Y/Y)Receivable fromcollaboration partner$13,416K Prepaid expenses andother current assets$7,790K (-10.44%↓ Y/Y)Contract asset$3,366K (-85.59%↓ Y/Y)Total current assets$807,148K (33.96%↑ Y/Y)Marketable securities -noncurrent$66,875K (-34.75%↓ Y/Y)Operating leaseright-of-use asset$6,946K (-19.13%↓ Y/Y)Property and equipment,net$3,456K (-15.87%↓ Y/Y)Other non-currentassets$832K Restricted cash -noncurrent$287K (-1.03%↓ Y/Y)Total assets$885,544K (23.33%↑ Y/Y)Total liabilities andstockholders' equity$885,544K (23.33%↑ Y/Y)Total stockholders'equity$841,543K (25.98%↑ Y/Y)Total liabilities$44,001K (-11.98%↓ Y/Y)Accumulated deficit-$304,039K (21.43%↑ Y/Y)Accumulated othercomprehensive (loss) income-$828K (-5420.00%↓ Y/Y)Additional paid-in capital$1,146,409K (8.67%↑ Y/Y)Total currentliabilities$37,181K (4.71%↑ Y/Y)Operating lease liability- noncurrent$6,820K (-25.10%↓ Y/Y)Common stock, 0.00001par value,...$1K (0.00%↑ Y/Y)Accrued expenses andother payables$21,667K (40.72%↑ Y/Y)Deferred revenue$9,659K (-34.24%↓ Y/Y)Accounts payable$3,459K (6.46%↑ Y/Y)Operating lease liability$2,396K (10.26%↑ Y/Y)

Protagonist Therapeutics, Inc (PTGX)

Protagonist Therapeutics, Inc (PTGX)